Literature DB >> 9836483

Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.

S L Parsons1, S A Watson, H M Collins, N R Griffin, P A Clarke, R J Steele.   

Abstract

The aim of the study was to investigate expression of the active and inactive gelatinases (MMP-2 and -9) in colorectal neoplasia and gastric cancer compared with normal mucosa. A total of 53 colorectal cancers and corresponding normal mucosa were studied using gelatin zymography as well as 15 colorectal adenomas and 13 gastric cancers with corresponding normal mucosa. Overexpression of all the gelatinases occurs in both colorectal and gastric cancer, with activation of MMP-2 appearing to be a feature of the malignant phenotype. Overexpression of MMP-9 occurs in colorectal adenomas. The gelatinases are overexpressed in gastrointestinal neoplasia, suggesting that these enzymes may have an important role in tumour invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836483      PMCID: PMC2063205          DOI: 10.1038/bjc.1998.712

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  41 in total

Review 1.  Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors:  E D Harris
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

2.  Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression.

Authors:  A D'Errico; S Garbisa; L A Liotta; V Castronovo; W G Stetler-Stevenson; W F Grigioni
Journal:  Mod Pathol       Date:  1991-03       Impact factor: 7.842

Review 3.  Collagen and collagenase: pregnancy and parturition.

Authors:  J J Jeffrey
Journal:  Semin Perinatol       Date:  1991-04       Impact factor: 3.300

Review 4.  Changing views of the role of matrix metalloproteinases in metastasis.

Authors:  A F Chambers; L M Matrisian
Journal:  J Natl Cancer Inst       Date:  1997-09-03       Impact factor: 13.506

5.  A new prognostic classification of rectal cancer.

Authors:  J R Jass; S B Love; J M Northover
Journal:  Lancet       Date:  1987-06-06       Impact factor: 79.321

Review 6.  The role of inflammatory mediators in the pathogenesis of periodontal disease.

Authors:  R C Page
Journal:  J Periodontal Res       Date:  1991-05       Impact factor: 4.419

7.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

8.  Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin).

Authors:  K Suzuki; J J Enghild; T Morodomi; G Salvesen; H Nagase
Journal:  Biochemistry       Date:  1990-11-06       Impact factor: 3.162

9.  Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

Authors:  P D Brown; A T Levy; I M Margulies; L A Liotta; W G Stetler-Stevenson
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

10.  Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues.

Authors:  S Yamagata; Y Yoshii; J G Suh; R Tanaka; S Shimizu
Journal:  Cancer Lett       Date:  1991-07-26       Impact factor: 8.679

View more
  42 in total

1.  Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; John B Willett
Journal:  Hum Pathol       Date:  2011-01-15       Impact factor: 3.466

2.  Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis.

Authors:  K Fazekas; O Csuka; I Köves; E Rásó; J Tímár
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.

Authors:  Kunpeng Ma; Limin Ma; Zhaocheng Jian
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

4.  Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1.

Authors:  Daniel A Kuppers; Ke Lan; Jason S Knight; Erle S Robertson
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Withaferin A inhibits the proliferation of gastric cancer cells by inducing G2/M cell cycle arrest and apoptosis.

Authors:  Green Kim; Tae-Hyoun Kim; Eun-Ha Hwang; Kyu-Tae Chang; Jung Joo Hong; Jong-Hwan Park
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

6.  Semaphorin 5A, an axon guidance molecule, enhances the invasion and metastasis of human gastric cancer through activation of MMP9.

Authors:  Guoqing Pan; Xiangling Zhang; Junyu Ren; Jianbo Lu; Wenliang Li; Hongmei Fu; Shufang Zhang; Jun Li
Journal:  Pathol Oncol Res       Date:  2012-07-21       Impact factor: 3.201

Review 7.  Molecular pathology of tumor metastasis. I. Predictive pathology.

Authors:  J Tímár; O Csuka; Z Orosz; A Jeney; L Kopper
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

8.  Angiotensin II type 1 receptor expression in human gastric cancer and induces MMP2 and MMP9 expression in MKN-28 cells.

Authors:  Wei Huang; Li-Fen Yu; Jie Zhong; Min-Min Qiao; Feng-Xiang Jiang; Fang Du; Xiang-Long Tian; Yun-Lin Wu
Journal:  Dig Dis Sci       Date:  2007-05-08       Impact factor: 3.199

9.  Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones.

Authors:  Yue-Hu Han; Bo Gao; Jing-Hui Huang; Zhen Wang; Zheng Guo; Qiang Jie; Liu Yang; Zhuo-Jing Luo
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

10.  Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.

Authors:  Piotr Daniel; Malgorzata Wagrowska-Danilewicz; Marian Danilewicz; Olga Stasikowska; Ewa Malecka-Panas
Journal:  Int J Colorectal Dis       Date:  2007-03-30       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.